$4,114.36 travel Payment -- Teva Pharmaceuticals to Dr. Scott Collins

Teva Pharmaceuticals covers $4,114.36 in travel for Dr. Scott Collins related to Farxiga

This page provides a detailed analysis of a $4,114.36 travel payment from Teva Pharmaceuticals to Dr. Scott Collins. Data is from the CMS Open Payments (Sunshine Act) database.

Payment Details

FieldValue
Amount$4,114.36
Payment Typetravel
Payment NatureTravel and Lodging
Pharmaceutical CompanyTeva Pharmaceuticals
PhysicianDr. Scott Collins
NPI Number1509998082
Physician SpecialtyPain Management
LocationCity, MD
Date of Payment2024-05-09
Related Drug/DeviceFarxiga
Conflict AssessmentModerate -- Worth Noting

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

Teva Pharmaceuticals made a $4.1K travel payment to Scott Collins, a Pain Management specialist in City, MD. The payment was associated with Farxiga. The payment of $4,114.36 to Dr. Scott Collins from Teva Pharmaceuticals for travel and lodging related to Farxiga is a significant expense. This payment occurred on May 9, 2024, indicating a recent engagement between the pharmaceutical company and the physician. The nature of the payment, 'Travel and Lodging,' suggests it may cover expenses for conferences, educational events, or site visits.

Patient Guidance: What This Payment Means for You

If you are a patient, understand that your doctor may receive payments from pharmaceutical companies for various reasons, including travel expenses, which are publicly disclosed. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

For a Pain Management specialist, travel and lodging payments related to a diabetes medication like Farxiga may be unusual and warrant further context regarding the educational or research purpose.

Regulatory Context: Sunshine Act Requirements

Payments made by pharmaceutical companies to physicians are subject to disclosure under the Sunshine Act (Physician Payments Sunshine Act) to promote transparency in healthcare.

Related Topics

This payment is related to the following healthcare transparency topics:

Understanding travel Payments

Travel and lodging payments cover transportation and accommodation expenses for physicians attending conferences, advisory board meetings, or speaking engagements sponsored by pharmaceutical companies. These payments can be substantial, particularly for international travel or multi-day events.

Frequently Asked Questions About This Payment

What was this $4.1K payment for?

This was a travel payment of $4.1K from Teva Pharmaceuticals to Scott Collins, categorized as "Travel and Lodging". It was associated with Farxiga. The payment was reported under the Sunshine Act (CMS Open Payments).

Does Scott Collins accept pharmaceutical money?

Yes, Scott Collins received this $4.1K payment from Teva Pharmaceuticals. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Scott Collins's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this travel payment?

A travel payment of $4.1K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Pain Management?

To compare this payment against Pain Management averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Pain Management physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about Scott Collins's relationship with Teva Pharmaceuticals?

The payment amount is substantial for travel and lodging, warranting further investigation into the specific services provided. This $4.1K travel payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Pain Management?

The physician's specialty is Pain Management, and the drug mentioned is Farxiga, which is typically used for diabetes.

What should patients do after learning about this payment?

If you are a patient, understand that your doctor may receive payments from pharmaceutical companies for various reasons, including travel expenses, which are publicly disclosed.

What else should I know about this travel payment?

The payment ID 'OP-MNGJCR64-B1MQYH' can be used to retrieve more detailed information from the CMS Open Payments database.

Related Reports

Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.